Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.
Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Emmenegger M, et al. Among authors: sprinzl mf. PLoS Pathog. 2021 Dec 3;17(12):e1010118. doi: 10.1371/journal.ppat.1010118. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34860860 Free PMC article.
No Evidence for Classic Thrombotic Microangiopathy in COVID-19.
Falter T, Rossmann H, Menge P, Goetje J, Groenwoldt S, Weinmann A, Sivanathan V, Schulz A, Lemmermann NAW, Danckwardt S, Lackner KJ, Galle PR, Scharrer I, Lämmle B, Sprinzl MF. Falter T, et al. Among authors: sprinzl mf. J Clin Med. 2021 Feb 9;10(4):671. doi: 10.3390/jcm10040671. J Clin Med. 2021. PMID: 33572417 Free PMC article.
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission.
Häuser F, Sprinzl MF, Dreis KJ, Renzaho A, Youhanen S, Kremer WM, Podlech J, Galle PR, Lackner KJ, Rossmann H, Lemmermann NA. Häuser F, et al. Among authors: sprinzl mf. Med Microbiol Immunol. 2021 Jun;210(2-3):165-171. doi: 10.1007/s00430-021-00706-5. Epub 2021 Apr 15. Med Microbiol Immunol. 2021. PMID: 33856557 Free PMC article.
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19.
Hollerbach A, Müller-Calleja N, Pedrosa D, Canisius A, Sprinzl MF, Falter T, Rossmann H, Bodenstein M, Werner C, Sagoschen I, Münzel T, Schreiner O, Sivanathan V, Reuter M, Niermann J, Galle PR, Teyton L, Ruf W, Lackner KJ. Hollerbach A, et al. Among authors: sprinzl mf. J Thromb Haemost. 2021 Sep;19(9):2335-2347. doi: 10.1111/jth.15455. Epub 2021 Jul 22. J Thromb Haemost. 2021. PMID: 34242469 Free PMC article.
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.
Schwaegermann MK, Hobohm L, Rausch J, Reuter M, Griemert TF, Sivanathan V, Falter T, Sprinzl MF, Lackner KJ, Galle PR, Konstantinides S, Theobald M, von Auer C. Schwaegermann MK, et al. Among authors: sprinzl mf. Hamostaseologie. 2023 Jun;43(3):215-218. doi: 10.1055/a-1497-1054. Epub 2021 Jul 29. Hamostaseologie. 2023. PMID: 34327693 Free article.
Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.
Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Emmenegger M, et al. Among authors: sprinzl mf. PLoS Pathog. 2022 Feb 2;18(2):e1010289. doi: 10.1371/journal.ppat.1010289. eCollection 2022 Feb. PLoS Pathog. 2022. PMID: 35108341 Free PMC article.
Response: Frailty assessment in the COVID-19 pandemic.
Labenz C, Schattenberg JM, Wörns MA, Sprinzl MF. Labenz C, et al. Among authors: sprinzl mf. J Investig Med. 2020 Oct;68(7):1302. doi: 10.1136/jim-2020-001556. Epub 2020 Aug 13. J Investig Med. 2020. PMID: 32792337 No abstract available.
78 results